A Switch Therapy for Community-acquired Pneumonia: A Randomized Controlled Trial.
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2011
At a glance
- Drugs Garenoxacin (Primary) ; Sulbactam/ampicillin
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- 27 Oct 2011 Results presented at the 77th Annual Meeting of the American College of Chest Physicians: Chest 2011.
- 23 Jul 2011 Actual end date (Mar 2011) as reported by University Hospital Medical Information Network - Japan.
- 23 Jul 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.